Abstract
To investigate if the PI-RADS score represents an effective tool in detecting prostate cancer in patients treated with a 5α-reductase inhibitor (dutasteride) and to identify dedicated total serum PSA and PSA density thresholds. Between April 2015 and March 2018, 75 patients under dutasteride treatment underwent multi-parametric magnetic resonance imaging (mpMRI) scans and US/MRI fusion prostate biopsy. Lesions were classified into two groups: Group 1 included PI-RADS 4 and 5 lesions, whilst Group 2 included PI-RADS 3-4-5 lesions. Lesions in groups 1 and 2 were further divided according to the patients' history of previous prostate biopsy. Ninety-seven lesions were detected. In PI-RADS 4-5 group, mpMRI showed a sensitivity of 78.0% and a specificity of 78.7%. The positive predictive value (PPV) was 79.6% and the negative predictive value (NPV) 77.1%. In PI-RADS 3-4-5 group, sensitivity was 100%, specificity 21.3%, PPV 57.5%, NPV 100%. In PI-RADS 4-5 biopsy-naive group sensitivity was 71.4%, specificity 75.0%. PPV 78.9% and NPV 66.7%. In PI-RADS 4-5 non-biopsy-naive group sensitivity was 82.8%, specificity 80.6%, PPV 80%, and NPV 83.3%. PI-RADS 3-4-5 biopsy-naive group showed sensitivity 100%, specificity 31.3%, PPV 65.6%, NPV 10...Continue Reading
References
Jan 26, 2005·Urology·Kenneth A IczkowskiDavid G Bostwick
Mar 27, 2007·The Journal of Urology·Leonard S MarksTimothy H Wilson
Apr 2, 2010·The New England Journal of Medicine·Gerald L AndrioleUNKNOWN REDUCE Study Group
Mar 26, 2011·BJU International·Hans T ChungMack Roach Iii
Jan 27, 2012·Lancet·Neil E FleshnerRoger S Rittmaster
Oct 23, 2012·Contemporary Clinical Trials·N L RobertsonM Emberton
Nov 28, 2012·European Urology·Fritz SchröderRamiro Castro
Dec 9, 2014·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Laurence KlotzJoseph Chin
Nov 23, 2016·The Journal of Urology·Caroline M MooreMark Emberton
Feb 7, 2017·NMR in Biomedicine·Olga StarobinetsSusan M Noworolski
May 20, 2017·European Radiology·Francesco GigantiAlex Kirkham
Mar 24, 2018·BJU International·Andreas MaxeinerHannes Cash
May 14, 2018·Urologic Oncology·Abhinav SidanaPeter A Pinto
Mar 23, 2019·European Urology·Baris TurkbeyJeffrey C Weinreb
May 18, 2019·European Urology Oncology·Christophe K MannaertsMonique J Roobol